| ISSN |
1949-8470 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Radiology, Nuclear Medicine & Medical Imaging |
| Manuscript Type |
Minireviews |
| Article Title |
Current status quo on COVID-19 including chest imaging
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rishi Philip Mathew, Merin Jose, Vinayak Jayaram, Paul Joy, Danny George, Maria Joseph, Teena Sleeba and Ajith Toms |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rishi Philip Mathew, Visiting Professor, MBBS, Doctor, Doctor, Department of Radiology, Rajagiri Hospital, Chunangamvelu, Aluva, Kochi 683112, Kerala, India. dr_rishimathew@yahoo.com |
| Key Words |
COVID-19; SARS-CoV-2; Coronavirus disease; Reverse transcriptase polymerase chain reaction; Viral pneumonia; Computed tomography |
| Core Tip |
As per the recommendations of various national and international organizations, chest imaging [chest radiograph/computed tomography (CT)] is not indicated as a screening tool in asymptomatic coronavirus disease 2019 (COVID-19) patients or in those with mild respiratory features unless the patients are at risk for disease progression. However, these suggestions remain a subject of debate as many studies have shown that especially chest CT can identify lung findings in patients with negative reverse transcriptase polymerase chain reaction or even before the test becomes positive. An added advantage with chest CT is that, based on the lung findings, CT can classify patients into mild, moderate or severe disease category, as patients with more extensive pulmonary disease may benefit from follow-up CTs and potential management options, taking into consideration that the disease has the potential to cause fibrosis. Several chest CT findings typical for COVID-19 have been reported, with the most common one being multifocal ground glass opacities or consolidation usually in a bilateral, peripheral, subpleural, lower lobe and posterior distribution. |
| Publish Date |
2020-12-28 13:46 |
| Citation |
Mathew RP, Jose M, Jayaram V, Joy P, George D, Joseph M, Sleeba T, Toms A. Current status quo on COVID-19 including chest imaging. World J Radiol 2020; 12(12): 272-288 |
| URL |
https://www.wjgnet.com/1949-8470/full/v12/i12/272.htm |
| DOI |
https://dx.doi.org/10.4329/wjr.v12.i12.272 |
